rfk jr glp-1 Doctors say Jr.'s anti-Ozempic stance perpetuates stigma and misrepresents evidence Rfk Jr Glp 1 Ozempic

Records were reviewed for patient characteristics and medication type and doses

Any PBM reforms should seek to remove distortions from the marketand, in particular, distortions created by government policies.

Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)

Purpose of Review: This article summarizes the medical management of obesity with an emphasis on incretin-based therapeutics that target the neuro-hormonal basis of obesity.Recent Findings: Medications that mimic the effect of incretins, a group of peptide hormones released in response to nutrient intake that regulate appetite, result in potent and durable weight loss